Hussman Strategic Advisors, Inc. Shockwave Medical, Inc. Transaction History

Hussman Strategic Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$191.17 - $325.63 $401,457 - $683,823	2,100 Added 20.0%	12,600 $4.1 Million
Q3 2023 Nov 07, 2023	BUY	$194.33 - $283.97 $221,536 - $323,725	1,140 Added 12.18%	10,500 $2.09 Million
Q2 2023 Aug 03, 2023	BUY	$223.05 - $302.68 $704,838 - $956,468	3,160 Added 50.97%	9,360 $2.67 Million
Q1 2023 May 04, 2023	BUY	$175.41 - $217.92 $1.09 Million - $1.35 Million	6,200 New	6,200 $1.34 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.